Practical considerations in the management of shock complicating acute myocardial infarction. A summary of current practice.
D000208:Acute Disease; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D001285:Atropine / Q000627:therapeutic use; D001795:Blood Pressure Determination; D002496:Central Venous Pressure; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004562:Electrocardiography; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D004091:Hydromorphone / Q000627:therapeutic use; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008614:Meperidine / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D009020:Morphine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D009638:Norepinephrine / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D012770:Shock, Cardiogenic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*
D004071:Digitalis Glycosides; D009020:Morphine; D001285:Atropine; D008680:Metaraminol; D008012:Lidocaine; D008614:Meperidine; D007545:Isoproterenol; D004091:Hydromorphone; D009638:Norepinephrine